Featured

Relativity last month announced that it was notifed by Nasdaq of non-compliance with multiple listing rules and faces removal from the exchange.

Terms call for the target to receive up to $105.78 million.

Terms include a minimum cash condition of $70 million (net of expenses) and the deal is expected to provide a minimum of $87 million of gross cash proceeds.

Cascadia has $150 million of cash in trust. Proceeds for the transaction are expected to consist of remaining cash in trust following any redemptions and up to $35 million of additional financing.

Tokyo-based SBC Medical Group specializes in medical care and special treatment including cosmetic surgery, infertility, dental, and orthopedics.

The SPAC is affiliated with Bernard Arnault, the world’s richest man. Terms call for the luxury EV maker to receive up to $288 million from the SPAC's trust account, assuming no redemptions.

The deal is expected to deliver approximately $68 million to Cheche Technology (assuming no further redemptions by Prime Impact shareholders).

Estimated cash proceeds consist of Denali's $85.4 million in trust. The combined company may also seek a $30 million pre-transaction PIPE.

In addition to the $90 million base consideration, the deal includes another potential $20 million in earnout over two years, subject to certain target revenues.

All of APRINOIA's existing shareholders will roll 100% of their shares into the merged enterprise, when they would then hold between 42% and 74% of the combined company depending on redemptions.